CYTOSORBENTS CORP (CTSO)
US23283X2062 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.69M | 14.13M | 22.14M | 52.14M | 71.42M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 6.63M | 6.06M | 5.66M | 4.52M | 5.16M | |||
| Inventories | 3.25M | 3.68M | 3.46M | 4.77M | 2.67M | |||
| Other Current Assets | 1.03M | 1.83M | 2.49M | 2.87M | 3.20M | |||
| Total Current Assets | 16.60M | 25.70M | 33.76M | 64.30M | 82.45M | |||
| Non-Current Assets | ||||||||
| PPE Net | 20.92M | 22.12M | 23.35M | 18.57M | 3.15M | |||
| Intangibles | N/A | 3.91M | 4.39M | 4.70M | 4.22M | |||
| Other Non-Current Assets | 10.29M | 1.54M | 1.73M | 1.94M | 130.00K | |||
| Total Non-Current Assets | 31.21M | 27.56M | 29.47M | 25.22M | 7.50M | |||
| TOTAL ASSETS | 47.80M | 53.26M | 63.23M | 89.52M | 89.95M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 2.50M | N/A | N/A | 0.00 | |||
| Accrued Expenses | 5.25M | 6.68M | 4.68M | 6.47M | 8.01M | |||
| Accounts Payable | 2.34M | 3.80M | 1.66M | 2.81M | 1.84M | |||
| Other Current Liabilities | 837.59K | 1.56M | 3.38M | 4.41M | 310.00K | |||
| Total Current Liabilities | 8.43M | 14.55M | 9.71M | 13.69M | 10.15M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 13.81M | 2.54M | 5.00M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 12.57M | 12.90M | 13.14M | 13.25M | 580.00K | |||
| Total Non-Current Liabilities | 26.37M | 15.44M | 18.15M | 13.25M | 580.00K | |||
| TOTAL LIABILITIES | 34.80M | 29.99M | 27.86M | 26.94M | 10.73M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -295.34M | -282.51M | -254.00M | -221.19M | -196.63M | |||
| Additional Paid In Capital | 308.44M | 305.20M | 287.00M | 283.19M | 277.53M | |||
| Common Shares | 54.50K | 54.24K | 40.00K | 40.00K | 40.00K | |||
| Other Shareholders' Equity | -156.93K | 529.32K | 2.33M | 530.00K | -1.73M | |||
| Shares Outstanding | 54.50M | 54.24M | 43.64M | 43.48M | 43.22M | |||
| Tangible Book Value per Share | 0.24 | 0.36 | 0.71 | 1.33 | 1.74 | |||
| Total Shareholders' Equity | 13.00M | 23.28M | 35.37M | 62.58M | 79.22M | |||
| TOTAL LIABILITIES AND EQUITY | 47.80M | 53.26M | 63.23M | 89.52M | 89.95M | |||
| Statistics | ||||||||
| Debt/Equity | 1.06 | 0.11 | 0.14 | N/A | N/A | |||
| Current Ratio | 1.97 | 1.77 | 3.48 | 4.70 | 8.12 | |||
| Return On Assets (ROA) | -39.06% | -53.52% | -51.89% | -27.44% | -8.72% | |||
| Return On Equity (ROE) | -143.63% | -122.48% | -92.76% | -39.25% | -9.90% | |||
All data in USD , ROIC based on taxRate of 0.21